Résumé

2 Live webinars tailored for healthcare professionals across Canada, featuring internationally renowned breast cancer expert Dr. Charles Geyer. Each session will be moderated by a leading Canadian oncologist from opposite coasts - Dr. Karen Gelmon (West Coast, Oct. 6th) and Dr. Stephanie Wong (East Coast, Oct. 7th) - to provide Canadian insights and perspectives.

This activity has been funded by an educational grant from AstraZeneca and is intended for healthcare practitioners only.

Points Saillants

  • 1

    Clinical considerations for germline BRCA (gBRCA) testing in early-stage breast cancer

  • 2

    Recent updates to the therapeutic landscape and emerging clinical challenges

  • 3

    Evidence supporting the integration of PARP inhibitors into treatment plans for patients with gBRCAm early TNBC and HR+/HER2- BC

  • 4

    Real-world patient case reviews exploring strategies for managing and supporting patients on PARP therapy

User

Charles E. Geyer Jr., MD, FACP

Medical Oncologist, Professor of Medicine, University of Pittsburgh Medical Center

User

Stephanie M Wong, MD, MPH, FRCSC

Breast Surgical Oncology, Jewish General Hospital, Associate Professor, McGill University Medical School

Commentaires (0)